A Study of Filanesib (ARRY-520) and Carfilzomib in Patients With Advanced Multiple Myeloma
Clinical trial NCT01989325 · COMPLETED
Trial details
- NCT number
- NCT01989325
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-11-01
- Primary completion
- 2016-02-01
- Enrollment
- 77
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.